Toward rational fresh frozen plasma transfusion: The effect of plasma transfusion on coagulation test results

American Journal of Clinical Pathology

Volumn 126, Issue 1, 2006, Pages 133-139

  Holland, Lorne L ^a   Brooks, Jay P ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Blood banking; Clinical pathology; Coagulation; Transfusion medicine

Indexed keywords

FRESH FROZEN PLASMA;

ADULT; ARTICLE; BLOOD CLOTTING TEST; CONTROLLED STUDY; EXPOSURE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; PLASMA TRANSFUSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTHROMBIN TIME; RELIABILITY; RISK REDUCTION;

EID: 33745783733     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/NQXHUG7HND78LFFK     Document Type: Article

References (58)

1. National Institutes of Health Consensus Development Conference. Fresh-frozen plasma: indications and risks. JAMA. 1985;253:551-553.
2. Feng CS, Chan YS, Leong S, et al. Guidelines for the appropriate use of fresh frozen plasma. J Hong Kong Med Assoc. 1990;42:106-108.
3. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Guidelines for the use of fresh frozen plasma. Transfus Med. 1992;2:57-63.
4. Stehling L, Luban NL, Anderson KC, et al. Guidelines for blood utilization review. Transfusion. 1994;34:438-448.
5. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. JAMA. 1994;271:777-781.
6. Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology. 1996;84:732-747.
7. Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. ACOG technical bulletin. Blood component therapy. No. 199, November 1994 (replaces No. 78, July 1984). Int J Gynaecol Obstet. 1995;48:233-238.
8. Expert Working Group. Guidelines for red blood cell and plasma transfusion for adults and children. CMAJ. 1997;156(11 suppl):S1-S24.
9. Japanese Ministry of Health and Welfare. Guideline for usage of blood products, 1999. Available at http://www.hokkaido. bc.jrc.or.jp/inform/ information210_eng.htm. Accessed November 1, 2005.
10. Irish Clinical Resources Efficiency Support Team. Better use of blood in Northern. Ireland: guidelines for blood transfusion practice, 2001. Available at http://www.crestni.org.uk/publications/blood_transfusion.pdf. Accessed November 1, 2005.
11. National Health and Medical Research Council. Clinical practice guidelines on the use of blood components (red blood cells, platelets, fresh frozen plasma, cryoprecipitate), 2001. Available at http://www.nhmrc.gov.au/ publications/_files/cp78.pdf. Accessed November 1, 2005.
12. American Red Cross. Practice guidelines for blood transfusion: A compilation from recent peer-reviewed literature, 2002. Available at http://www.redcrossblood.com/pgbtprint.pdf. Accessed November 1, 2005.
13. Medical Directors of the South African Blood Service, eds. Clinical guidelines for the use of blood products in South Africa. 3rd ed. 2003. Available at http://www.doh.gov.za/docs/factsheets/guidelines/bp3/part1.pdf. Accessed November 1, 2005.
14. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004;126:11-28.
15. New York State Council on Human Blood and Transfusion Services. Guidelines for the administration of plasma, 2004. Available at http://www.wadsworth.org/labcert/blood_ tissue/FFPadminfinal1204.pdf. Accessed November 1, 2005.
16. Brien WF, Butler RJ, Inwood MJ. An audit of blood component therapy in a Canadian general teaching hospital. CMAJ. 1989;140:812-815.
17. Mozes B, Epstein M, Ben-Bassat I, et al. Evaluation of the appropriateness of blood and blood product transfusion using preset criteria. Transfusion. 1989;29:473-476.
18. Dzik W, Rao A. Why do physicians request fresh frozen plasma [letter]? Transfusion. 2004;44:1393-1394.
19. Tuckfield A, Haeusler MN, Grigg AP, et al. Reduction of inappropriate use of blood products by prospective monitoring of transfusion request forms. Med J Aust. 1997;167:473-476.
20. Snyder AJ, Gottschall JL, Menitove JE. Why is fresh-frozen plasma transfused? Transfusion. 1986;26:107-112.
21. Stanworth SJ, Brunskill SJ, Hyde CJ. Is fresh frozen plasma clinically effective? a systematic review of randomized controlled trials. Br J Haematol. 2004;126:139-152.
22. Segal JB, Dzik WH, Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005;45:1413-1425.
23. Holland LL, Foster TM, Marlar RA, et al. Fresh frozen plasma is ineffective for correcting minimally elevated international normalized ratios [letter]. Transfusion. 2005;45:1234-1235.
24. Counts RB, Haisch C, Simon TL, et al. Hemostasis in massively transfused trauma patients. Ann Surg. 1979;190:91-99.
25. Murray DJ, Olson J, Strauss R, et al. Coagulation changes during packed red cell replacement of major blood loss. Anesthesiology. 1988;69:839-845.
26. Ciavarella D, Reed RL, Counts RB, et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol. 1987:67:365-368.
27. Silver H, Tahhan HR, Anderson J, et al. A non-computer-dependent prospective review of blood and blood component utilization. Transfusion. 1992;32:260-265.
28. Metz J, McGrath KM, Copperchini ML, et al. Appropriateness of transfusions of red cells, platelets and fresh frozen plasma: an audit in a tertiary care teaching hospital. Med J Aust. 1995;162:572-573, 576-577.
29. Shaikh BS, Wagar D, Lau PM, et al. Transfusion pattern of fresh frozen plasma in a medical school hospital. Vox Sang. 1985;48:366-369.
30. Schofield WN, Rubin GL, Dean MG. Appropriateness of platelet, fresh frozen plasma and cryoprecipitate transfusion in New South Wales public hospitals. Med J Aust. 2003;178:117-121.
31. Solomon RR, Clifford JS, Gutman SI. The use of laboratory intervention to stem the flow of fresh-frozen plasma. Am J Clin Pathol. 1988;89:518-521.
32. Tobin SN, Campbell DA, Boyce NW. Durability of response to a targeted intervention to modify clinician transfusion practices in a major teaching hospital. Med J Aust. 2001;174:445-448.
33. Luk C, Eckert KM, Barr RM, et al. Prospective audit of the use of fresh-frozen plasma, based on Canadian Medical Association transfusion guidelines. CMAJ. 2002;166:1539-1540.
34. Silbert JA, Bove JR, Dubin S, et al. Patterns of frozen plasma use. Conn Med. 1981;45:507-511.
35. Barnette RE, Fish DJ, Eisenstaedt RS. Modification of fresh-frozen plasma transfusion practices through educational intervention. Transfusion. 1990;30:253-257.
36. Blumberg N, Laczin J, McMican A, et al. A critical survey of fresh-frozen plasma use. Transfusion. 1986;26:511-513.
37. Kakkar N, Kaur R, Dhanoa J. Improvement in fresh frozen plasma transfusion practice: results of an outcome audit. Transfus Med. 2004;14:231-235.
38. Thomson A, Contreras M, Knowles S. Blood component treatment: a retrospective audit in five major London hospitals. J Clin Pathol. 1991;44:734-737.
39. National Blood Service. Blood matters, August 2000. Available at http://www.blood.co.uk/hospitals/library/bm/issue4/issue4_aug00.PDF. Accessed November 1, 2005.
40. Schots J, Steenssens L. Blood usage review in a Belgian university hospital. Int J Qual Health Care. 1994;6:41-45.
41. Cheng G, Wong HF, Chan A, et al. The effects of a self-educating blood component request form and enforcements of transfusion guidelines on FFP and platelet usage. Clin Lab Haematol. 1996;18:83-87.
42. Chaudhary R, Singh H, Verma A, et al. Evaluation of fresh frozen plasma usage at a tertiary care hospital in North India. ANZ J Surg. 2005;75:573-576.
43. Chng WJ, Tan MK, Kuperan P. An audit of fresh frozen plasma usage in an acute general hospital in Singapore. Singapore Med J. 2003;44:574-578.
44. Marti-Carvajal AJ, Munoz-Navarro SR, Pena-Marti GE, et al. An audit of appropriate use of blood products in adult patients in a Venezuelan general university hospital. Int J Qual Health Care. 1999;11:391-395.
45. Pita-Ramirez L, Cabrera Carbajal BE, Ortega Zavala C. Reasons for fresh frozen plasma transfusion in a general hospital. Rev Invest Clin. 1999;51:89-92.
46. Abdel-Wahab O, Healy B, Dzik WH. Effect of fresh frozen plasma (FFP) on prothrombin time (PT) and bleeding in patients with mild coagulation abnormalities [abstract]. Transfusion. 2005;45:141A.
47. Lassen JF, Kjeldsen J, Antonsen S, et al. Interpretation of serial measurements of international normalized ratio for prothrombin times in monitoring oral anticoagulant therapy. Clin Chem. 1995;41:1171-1176.
48. Kjeldsen J, Lassen JF, Petersen PH, et al. Biological variation of international normalized ratio for prothrombin times, and consequences in monitoring oral anticoagulant therapy: computer simulation of serial measurements with goal-setting for analytical quality. Clin Chem. 1997;43:2175-2182.
49. Costongs GM, Bas BM, Janson PC, et al. Short-term and long-term intra-individual variations and critical differences of coagulation parameters. J Clin Chem Clin Biochem. 1985;23:405-410.
50. Wada Y, Kurihara M, Toyofuku M, et al. Analytical goals for coagulation tests based on biological variation. Clin Chem Lab Med. 2004;42:79-83.
51. Makris M, Greaves M, Phillips WS, et al. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost. 1997;77:477-480.
52. Chowdhury P, Saayman AG, Paulus U, et al. Efficacy of standard dose and 30 mL/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol. 2004;125:69-73.
53. Aggeler P. Physiological basis for transfusion therapy in hemorrhagic disorders: a critical review. Transfusion. 1961;1:71-86.
54. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 2002;42:975-979.
55. Domen RE, Hoeltge GA. Allergic transfusion reactions: an evaluation of 273 consecutive reactions. Arch Pathol Lab Med. 2003;127:316-320.
56. Popovsky MA. Transfusion and the lung: circulatory overload and acute lung injury. Vox Sang. 2004;87:62-65.
57. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44:1774-1789.
58. Bux J. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang. 2005;89:1-10.